Invesco Biotechnology & Genome ETF
PBE
PBE
71 hedge funds and large institutions have $75.4M invested in Invesco Biotechnology & Genome ETF in 2018 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 11 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
71
Holders Change
-3
Holders Change %
-4.05%
% of All Funds
1.58%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
22
Reduced
11
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
HighTower Advisors
Chicago,
Illinois
|
$5.88M |
2 |
Morgan Stanley
New York
|
$9.69M |
3 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
$2.36M |
4 |
Bank of America
Charlotte,
North Carolina
|
$4.51M |
5 |
PA
PFG Advisors
Phoenix,
Arizona
|
$1.6M |